Drug news
FDA approves Absorica (Ranbaxy) for severe Acne
FDA has approved Absorica on 25 May 2012, a patented formulation of isotretinoin, as a treatment for severe recalcitrant nodular acne. Ranbaxy is expected to launch Absorica in the USA in the fourth-quarter 2012.